CMPX - Compass Therapeutics

-

$undefined

N/A

(N/A)

Compass Therapeutics NASDAQ:CMPX

Location: | Industry: Biological Product (except Diagnostic) Manufacturing | Sector: Manufacturing


Market Cap

NaN

52 Wk Range

$ - $

Previous Close

$N/A

Open

$N/A

Day Range

N/A - N/A

Volume

N/A

Avg Volume

N/A

Enterprise Value

273.2M

Cash

135.4M

Avg Qtr Burn

-12.01M

Short % of Float

3.32%

Insider Ownership

18.17%

Institutional Own.

71.29%

Qtr Updated

09/30/24


Drug Pipeline

Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & IndicationStage & EventCatalyst Date

Phase 2/3

Data readout

CTX-471 +/- KEYTRUDA® (pembrolizumab) Details
Cancer, Small cell lung cancer, Non-small cell lung carcinoma, Melanoma

Phase 2

Initiation

Phase 2

Initiation

Phase 1

Data readout

IND

Submission